Timothy C. Barabe
CIK: 0001237409
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jul 22, 2026HTFL
Heartflow, Inc.
Exercise(M)Direct3.7K shares at avg. $19.00$70K - Jul 17, 2026HTFL
Heartflow, Inc.
Exercise(M)Direct5K shares at avg. $19.00$95K - Jun 16, 2026HTFL
Heartflow, Inc.
Award(A)DirectStock Option
16.1K shares at avg. $32.05- - Mar 11, 2026HTFL
Heartflow, Inc.
Exercise(M)Direct8.7K shares at avg. $2.22$19K - Feb 17, 2026HTFL
Heartflow, Inc.
Exercise(M)Direct2.5K shares at avg. $8.33$21K - Jan 2, 2026RNAC
Cartesian Therapeutics, Inc.
Award(A)Direct2.6K shares- - Dec 4, 2025RNAC
Cartesian Therapeutics, Inc.
Purchase(P)Direct30K shares at avg. $6.86$206K - Aug 11, 2025HTFL
Heartflow, Inc.
Conversion(C)Direct131.6K shares- - Aug 7, 2025HTFL
Heartflow, Inc.
Award(A)DirectStock Option
23.7K shares- - Jan 2, 2025RNAC
Cartesian Therapeutics, Inc.
Award(A)Direct2.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 22, 2026 |  HTFL Heartflow, Inc. | Exercise(M) | 3,710 | $19.00 | $70,490 | Direct |
| Jul 17, 2026 | HTFL Heartflow, Inc. | Exercise(M) | 5,000 | $19.00 | $95,000 | Direct |
| Jun 16, 2026 | HTFL Heartflow, Inc. | Award(A) Stock Option | 16,075 | $32.05 | - | Direct |
| Mar 11, 2026 | HTFL Heartflow, Inc. | Exercise(M) | 8,667 | $2.22 | $19,241 | Direct |
| Feb 17, 2026 | HTFL Heartflow, Inc. | Exercise(M) | 2,497 | $8.33 | $20,800 | Direct |
| Jan 2, 2026 |  RNAC Cartesian Therapeutics, Inc. | Award(A) | 2,600 | - | $0 | Direct |
| Dec 4, 2025 | RNAC Cartesian Therapeutics, Inc. | Purchase(P) | 30,000 | $6.86 | $205,797 | Direct |
| Aug 11, 2025 | HTFL Heartflow, Inc. | Conversion(C) | 131,578 | - | - | Direct |
| Aug 7, 2025 | HTFL Heartflow, Inc. | Award(A) Stock Option | 23,710 | - | - | Direct |
| Jan 2, 2025 | RNAC Cartesian Therapeutics, Inc. | Award(A) | 2,600 | - | $0 | Direct |
1-10 of 10 transactions
About BARABE TIMOTHY C
BARABE TIMOTHY C (SEC CIK 0001237409) files insider reports with the SEC as Director of Heartflow, Inc. (HTFL) and Director of Cartesian Therapeutics, Inc. (RNAC).
Signal8 holds 10 ownership filings by BARABE TIMOTHY C (1 Form 3, 9 Form 4), filed between Jan 6, 2025 and Jul 24, 2026. Those filings report 10 transactions, from Jan 2, 2025 to Jul 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BARABE TIMOTHY C's filings is in SAN FRANCISCO, CA.
Recent filings by BARABE TIMOTHY C
- Jul 22, 2026: Option exercise of HTFL shares (Form 4, code M).
- Jul 17, 2026: Option exercise of HTFL shares (Form 4, code M).
- Jun 16, 2026: Grant or award of HTFL derivative securities (Form 4, code A).
- Mar 11, 2026: Option exercise of HTFL shares (Form 4, code M).
- Feb 17, 2026: Option exercise of HTFL shares (Form 4, code M).
Other insiders filing for Heartflow, Inc. (HTFL)
- Rogers Campbell, Chief Medical Officer
- Farquhar John C.M., Chief Executive Officer
- Verghese Vikram, Chief Financial Officer
- Jones Marie L., Chief Accounting Officer
- Lightcap Jeffrey C, Director
- WELDON WILLIAM C, Director